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Introduction
Older African Americans are twice as likely to develop Alzheimer's disease (AD) as older non-Hispanic Caucasians. 1 Epidemiological and genome-wide association studies in clinically defined cases of dementia suggest that AD may manifest differently according to race, vascular risks, educational duration, and susceptibility genes. 1, 2 We previously reported that AD was associated with lower CSF tau-related biomarker levels in African Americans than Caucasians, despite similar levels of beta-amyloid 1-42 (Aβ42). 2 We did not find a difference in hippocampal volumes, but it is not known if other objective biomarkers differed between the two races. Here we analyze MRI biomarkers that may reflect earlier AD-related processes and may better inform the relationship between race and AD neuroimaging phenotypes.
In AD, disrupted functional connectivity in the default mode network (DMN) is reported to occur following amyloid biomarker changes but before significant hippocampal atrophy. 3, 4 We hypothesized that, similar to baseline and AD-associated differences in CSF tau biomarkers between the two racial groups, older African Americans also had AD-associated DMN alterations distinct from older Caucasians. To test this hypothesis, we analyzed resting state functional (rsf-) MRI from the same group of subjects with normal cognition (NC) or early AD (mild cognitive impairment or mild AD dementia, MCI/AD), and analyzed if race, diagnosis, and other factors influenced DMN connectivity measures.
Methods

Standard Protocol Approvals, Registrations, and Patient Consents:
This study was approved by the Emory University Institutional Review Board and written consent was obtained from all subjects.
Participants:
We included 78 participants who underwent uniform clinical, neuropsychological, genetic, and CSF biomarker analysis as previously described (Table e- (vmPFC), and the hippocampus. We used a data driven approach (Independent Component Analysis; ICA) using the Group ICA of fMRI Toolbox (GIFT) to identify large-scale brain networks, and calculated connectivity measures between DMN nodes. 5
Data availability
The data that support the findings of this study are available from the corresponding author, upon reasonable request.
Statistical Analyses
Statistical analysis was performed in R version 3.3.3. We constructed multivariate multiple linear regression models with intra-network connectivity between the three posterior DMN nodes as the dependent variables; race, sex, and diagnosis (normal cognition, MCI/AD), age, and mean framewise displacement (MFWD) as independent variables, as well as a higher order interaction term (race X diagnosis). Measures of connectivity between the anterior DMN component (vmPFC) and the hippocampus, PCUN, and PCC/IPL were similarly analyzed for raceassociated differences. We additionally examined the relationship of potential confounding effects of APOE ε4, ABCA7 risk allele, hypertension, and diabetes which differed between the races. 2 To determine possible functional consequences of race-associated differences in DMN connectivity, we also correlated DMN connectivity that differed between the races with domainspecific cognitive functions. In this model, domain-specific Z-scores for executive, memory, language, and visual spatial function were the dependent variable, and diagnosis (NC vs. MCI/AD), connectivity, age, and having at least one APOE ε4 allele were the independent variables.
Results
Race modifies the relationship between MCI/AD and midline core DMN connectivity
Consistent with published results, MCI/AD was associated with reduced anterior-posterior DMN connectivity (vmPFC-PCC/IPL and vmPFC-PCUN) and unchanged PCUN-PCC/IPL connectivity in older Caucasians, adjusting for age and gender ( Fig 1A) . Race modified the relationship between MCI/AD diagnosis and connectivity for all three examined midline node pairs. Unlike in Caucasians, MCI/AD was associated with increased PCUN-PCC/IPL connectivity in African Americans, and unchanged anterior-posterior DMN connectivity.
Further adjustment for ABCA7 and APOE genotypes showed similar results (Table 1) .
Race does not modify the relationship between MCI/AD and medial temporal DMN connectivity
Also consistent with published results, MCI/AD was associated with reduced connectivity involving the hippocampus in Caucasians (adjusting for age and gender, Fig 1B; hippocampus-PCUN, F(2, 75)=2.13, p=0.05; hippocampus-PCC/IPL, F (2, 75)=2.17, p=0.04).
Race did not influence hippocampal DMN connectivity, nor did it modify the relationship between MCI/AD and hippocampal connectivity.
Greater vmPFC-PCUN connectivity is associated with better memory
Finally, we determined if the connectivity profile differences between African Americans and Caucasians were associated with distinct neuropsychological profiles. Across the entire cohort, greater PCUN-PCC/IPL connectivity correlated with better memory functions independent of race ( Table 2 ). Because increased PCUN-PCC/IPL connectivity was associated with MCI/AD only in African Americans, these results together are in keeping with less amnestic MCI/AD profiles (at the group level) in African Americans than Caucasians.
Discussion
The biological underpinning for epidemiologic and phenotypic differences in AD between older African Americans and Caucasians remains poorly defined. Here we show that race altered MCI/AD-associated connectivity profiles in the midline core DMN subsystem but not the amyloid-associated medial temporal subsystem. These differences cannot be readily explained by genetic risks from ABCA7 and APOE alone, but likely have clinically meaningful impact as increased posterior midline DMN connectivity in African Americans with MCI/AD corresponds to their less amnestic neuropsychological profiles.
Race-related AD phenotypic differences have historically been attributed to education quality, access to health care, and cerebrovascular disease. 6 The lower CSF tau levels in older African Americans regardless of cognitive status cannot be adequately explained by these explanations, 2 and may correlate with midline DMN connectivity profiles. It remains controversial whether altered midline core connectivity reflects post mortem or in vivo measures of tau pathology, 8 but this subsystem correlates only marginally with cerebral amyloid deposition. 7 Increased DMN connectivity was previously linked to non-AD neurodegenerative diseases, and it is possible that greater non-AD co-pathology in African American AD cases on autopsy begins early rather than late following cerebral amyloid deposition. 9 Alternatively, increased connectivity may represent network compensation, which suggests greater -not less -cognitive reserve in African Americans with AD to account for their slower clinical progression. 10 Because there is significant overlap between the groupings, future work should prospectively analyze the relationship between tau PET tracer retention, CSF tau levels, and DMN connectivity in both Caucasians and African Americans. Because African Americans with MCI/AD also have a slower cognitive decline than Caucasians, PCUN-PCC/IPL connectivity -increased at the group level in African Americans -should also be tested as a prognostic biomarker in longitudinal studies.
While these findings extend our previous description of a specific AD endophenotype in African Americans, this study was limited by the number of rsf-MRI scans of insufficient quality, the association nature of the relationships between race and connectivity, and lack of neuropathologic correlate for connectivity differences. Nevertheless, when interpreted with previous data, this study lends further support to the notion that amyloid-related changes -CSF Aβ42 level, and medial temporal DMN connectivity -are common to African Americans and Caucasians in AD, but tau-related changes -CSF tau levels, midline core DMN connectivity, and clinical progression -are modified by race. Not only do these findings promote caution when generalizing AD diagnostic biomarkers developed in Caucasians to African Americans, they may also help refine the subject selection process for future disease modifying therapies.
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